178 related articles for article (PubMed ID: 9552442)
1. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release.
Ebube NK; Hikal AH; Wyandt CM; Beer DC; Miller LG; Jones AB
Pharm Dev Technol; 1997 May; 2(2):161-70. PubMed ID: 9552442
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
4. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
5. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies.
Wilson CG; Clarke CP; Starkey YY; Clarke GD
Drug Dev Ind Pharm; 2011 Jul; 37(7):747-53. PubMed ID: 21244275
[TBL] [Abstract][Full Text] [Related]
7. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
8. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
Nerurkar J; Jun HW; Price JC; Park MO
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
[TBL] [Abstract][Full Text] [Related]
9. Substituted amylose matrices for oral drug delivery.
Moghadam SH; Wang HW; Saddar El-Leithy E; Chebli C; Cartilier L
Biomed Mater; 2007 Mar; 2(1):S71-7. PubMed ID: 18458424
[TBL] [Abstract][Full Text] [Related]
10. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
11. Bead compacts. I. Effect of compression on maintenance of polymer coat integrity in multilayered bead formulations.
Altaf SA; Hoag SW; Ayres JW
Drug Dev Ind Pharm; 1998 Aug; 24(8):737-46. PubMed ID: 9876521
[TBL] [Abstract][Full Text] [Related]
12. Development of theophylline sustained release dosage form based on Kollidon SR.
Reza MS; Quadir MA; Haider SS
Pak J Pharm Sci; 2002 Jan; 15(1):63-70. PubMed ID: 16414869
[TBL] [Abstract][Full Text] [Related]
13. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
14. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
Bendas ER
Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
16. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
[TBL] [Abstract][Full Text] [Related]
17. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
Hiremath PS; Saha RN
Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251
[TBL] [Abstract][Full Text] [Related]
18. A study on maize proteins as a potential new tablet excipient.
Georget DM; Barker SA; Belton PS
Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
[TBL] [Abstract][Full Text] [Related]
19. Parameters affecting the drug release from in situ gelling nasal inserts.
Bertram U; Bodmeier R
Eur J Pharm Biopharm; 2006 Jul; 63(3):310-9. PubMed ID: 16513333
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
